Clinical Trial Update: A Phase 3 Study of HRS-8080 Versus Treatment Chosen by Physicians in Locally Advanced and Metastatic Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating HRS-8080 versus physician's choice in locally advanced and metastatic breast cancer; enrollment is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HRS-8080

Snippet

Sponsor: Shandong Suncadia Medicine Co., Ltd. | Conditions: Locally Advanced Breast Cancer, Metastatic Breast Cancer | Phase 3 | Status: RECRUITING